chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 1400 on 12/11/2022, Nurse, RN- Vaccinator notified Lead Nurse, RN, PHN about patient experienced loss of responsiveness for approximately 3 seconds with eyes rolling back after patient received the Pfizer Adult Bivalent booster dose (Lot: GJ6796, Exp:02/2023) in her left arm and Influenza dose (Lot: 9PG4D, Exp: 06/2023) on her right arm. Patient reaction was observed by nurse. At 1402 Nurse obtained vital signs; blood pressure: 98/64mmHg, heart rate: 87 bpm, oxygen saturation rate: 97%, respirations: 20 breaths per minute while sitting in chair. Patient reported to Nurse that she was experiencing a headache on her way to her today's COVID-19 vaccine appointment. Patient was offered water and cheese crackers by vaccination site staff. Per mother of patient, the patient had only a small bowl of cereal this morning. Patient's mother informed Lead Nurse that the patient had open-heart surgery in 2016, reported the patient does not take any medications, and has mild environmental allergies. Patient was transferred to an anti-gravity chair by Nurse. At 1415, nurse Nurse observed patient shaking and with pale skin. At 1417, 911 was activated by Lead Nurse, patient's vital signs were taken again by Nurse: heart rate: 100bpm, and oxygen saturation rate: 98%. Patient continued to experience shakiness and reported she was ?too cold." At 1433, Fire Department arrived and assumed care. At 1448 patient's mother declined transport to hospital. Patient's vital signs taken by Fire Dept: blood pressure: 100/62mmHg, respirations: 22, heart rate: 98bpm, and oxygen saturation rate: 98%. Lead Nurse educated patient's mother to follow-up with the patient's primary care provider. ER and urgent care precautions were provided. Patient's mother verbalized understanding. Patient and mother left vaccination site at 1450 with a steady gait and balance
Pt reports 3 day hx of Lt sided chest pain that radiates into midsternum. Pt reports pain is constant, feels like a throbbing and sharp pain and that it feels like her heart "is going to burst"
Sometime in May/June noticed enlarged lymph nodes and changes in my gums (recession, holes). Saw regular dentist for cleaning then based on their recommendation for not seeing an changes after 2 weeks I scheduled an appointment with an ENT and a periodontist. ENT prescribed antibiotics (Amoxicillin) for 10 days (finished end of July) and then follow-up with a CT scan (scheduled for Aug 12). They suggested the enlarged lymph nodes could be from a gum infection. The lymph nodes decreased in size after the antibiotics. Periodontist recommended deep cleaning would fix the gum issues and that has been scheduled for September.
When got up 18SEP small knot in arm; later that afternoon arm started to get red; the morning of 19SEP arm was red (area about a quarter) by the afternoon had gotten larger than fifty cent; this AM, 20SEP area red, hard & about size of 8cm;
On 1/19/22 I RN vaccinated patient. (DOB 12/20/2006) with Pfizer Covid-19 vaccine. After a few minutes patient scratched the injection area. Her mother came to me and said the patient felt a little itchy and asked for some medication to relieve that. I looked at the area and saw that it was a little red most likely from her scratching but there was no skin bumps present. I apply hydrocortisone 1% on the affected skin area and gave her 10 ml of diphenhydramine 12.5mg/5ml. After about 5 minutes the patient said she felt better. I recommended her mother to buy Benadryl (diphenhydramine) 25 mg capsules just in case. I asked her to let the pharmacy know if the condition got worse. Her mother never contacted the pharmacy. When she brought the patient for her second Pfizer vaccination on 12/09/2006, she mentioned to the pharmacist who did the second vaccination about the event. I was advised to file the report. I called the mother today 2/16/22 to find out about that day. She said there was no issue after they left and she never gave her the Benadryl.
PATIENT PREVIOUSLY RECIEVED 1 DOSE OF PFIZER VACCINE (1/26/2021-LOT EL0140)
Patient received an adult dose of HEP B instead of the pediatric dose of HEP B according to age. Notified patient and patient did not have an reaction complaint to HEP B dose.
1722 pt states to RN that he can?t see, feels weird. 97% SPO2, 67 HR, BP unable to get. Patient states that he did not eat anything today. Eyes appear to be dazed. 1726 states after drinking water that he is feeling better, sitting in chair he begins to drop his head back and front. RN assists patient to lay in Trendelenburg position and removed his sweatshirt. After a few minutes he states he feels better and is able to see. Bp 94/40, 97 % spo2, 81 hr. 1733 patient sitting and drinking lots of water. 100% SPO2, HR 100, 102/56. 1748 102/60, 99%, 90 HR, patient feeling better and left with dad.
on site of DTP lt leg swolled up and whelp around it, didn't get bettter as noc went on, which happen about 10 hrs p/shot was given;
Client is only 17 years old (and nine months). She received a dose of Moderna vaccine which is only meant for 18+ It was a clinic put on by the Health Department, but took place at a school to help vaccinate students.   No adverse reaction directly related to the vaccine that has been reported to the Health Department. But wanted to report due to the fact that she is underage and received the Moderna Vaccine when she should not have.
4 hours, post vax, pt began with facial swelling and flushed, fever and generalized.
injection site is still red; injection site/ warm to the touch; injection site/ very tender; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th June 2021, the patient received the 2nd dose of Shingrix. In June 2021, less than a day after receiving Shingrix, the patient experienced injection site erythema, injection site warmth and injection site tenderness. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site tenderness were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, injection site warmth and injection site tenderness to be related to Shingrix.  Additional details were provided as follows:  The reporter was the patient. The age at vaccination was not reported.  The patient received 2nd dose of Shingrix a little over 24 hours ago and experienced injection site redness, was warm to the touch, and very tender. The reporter asked how long should expect this to last.
Patient presented with 1 week of headache. She had some spontaneous bruising. She is thrombocytopenic in the 50s with a large intraparenchymal hemorrhage.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. No medical history, concurrent conditions and concomitant medications were reported. On unknown dates, multiple unspecified patients were vaccinated with VAQTA, lot # J016216, expiration date: 18-AUG-2016, (dose, administration route and site were not reported) after it was exposed to a supported temperature excursion of 32.9F for 2 hours and 45 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
dizzy; blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and VISION BLURRED (blurred vision) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy) and VISION BLURRED (blurred vision). At the time of the report, DIZZINESS (dizzy) and VISION BLURRED (blurred vision) outcome was unknown.            No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
pt recv vax 9DEC98 & child very wiggling during inj;mom called 11DEC98 w/cc: arm red, swollen, bruise @ site-child c/o pain @ site;now giving APAP;told to cont APAP PRN cold compress to arm;
Initial report was received on 07 October 2011 from a consumer who is also the patient. A male patient with a history of type I diabetes and allergies to CEFTIN and CEFZIL had received on 07 October 2011 an injection "above his deltoid" of INFLUENZA VACCINE (manufacturer, lot number and route of administration not reported) and upon vaccination his arm "felt weird". Two minutes after vaccination he "passed out" and states he has pain in his arm. Concomitant medications included LANTUS and HUMALOG. Illness at the time of vaccination and other vaccines given within four weeks of the suspect vaccine were not reported. Treatments were not reported. No further information was available at the time of the report. Outcome was reported as not recovered. Documents held by sender: none.
Back pain; Delayed her 2nd dose due to back pain after first dose; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) and INTENTIONAL PRODUCT USE ISSUE (Delayed her 2nd dose due to back pain after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Delayed her 2nd dose due to back pain after first dose). On an unknown date, the patient experienced BACK PAIN (Back pain). On 09-Mar-2021, INTENTIONAL PRODUCT USE ISSUE (Delayed her 2nd dose due to back pain after first dose) had resolved. At the time of the report, BACK PAIN (Back pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.  Patient back pain resolved after ten days of the first dose of Moderna vaccine.    This case was linked to MOD-2021-043188 (Patient Link).
I experienced immediate chest pain, chills, difficulty sleeping, numbness, dizziness when standing. Vomiting. Occasional elbow pain on left arm.
Initial report was received from a healthcare professional on 10 April 2012. The reporter for this case is the same as case number: 2012-03810 and 2012-03811. A 63-year-old female patient received a right deltoid (RD) intramuscular injection (dose one) of ADACEL, sanofi pasteur Ltd., lot number C4101AA on 22 March 2012. The patient's past medical history was reported as hypothyroid, arthritis, and hypertension. The patient denied any known drug allergies and denied illness at time of vaccination. Other vaccinations within four weeks prior to date of vaccination were reported as none. Concomitant medications included: SYNTHROID, CELEXA, AMBIEN, K-DUR, LASIX, ULTRAM, PRILOSEC, and FLONASE. "Seven days after vaccination" on questionably 29 March 2012, the patient presented with "cellulitis" at injection site, requiring a doctor visit. The patient experienced redness, induration, and swelling at injection site with fever, numbness and tingling of arm. She was treated with an antibiotic. The patient had not returned to office or reported persistent or further symptoms. The patient's outcome was reported as recovered on unspecified date. Documents held by sender: None.
Shingrix mixed with other diluent / inadvertently used sterile water to SHINGRIX; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 3FE44, expiry date 17-JUN-2024) for prophylaxis.   On 31-MAR-2023, the patient received the 2nd dose of Shingrix (intramuscular, right deltoid). On 31-MAR-2023, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: Shingrix mixed with other diluent / inadvertently used sterile water to SHINGRIX). The outcome of the wrong solution used in drug reconstitution was unknown.   Additional Information: GSK Receipt Date: 03-APR-2023 The reporter stated that they inadvertently used sterile water to reconstitute Shingrix and then administered to a patient. They did not use the adjuvant that comes in box, they used the diluent that comes with the Merk vaccines. Mixed different manufactured products in one syringe and then administered.  Shingrix reconstituted with merk sterile water diluent instead of the GlaxoSmithKline supplied diluent, which led to wrong solution used in drug reconstitution. The reporter consented to follow up.
Pt came in for a Covid-Bivalent Vaccine and was given the Covid Vaccine
expired dose was administered; This case was reported by a nurse and described the occurrence of expired vaccine used in a 17-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 9L39Z, expiry date 8th October 2021) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th October 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 28th October 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient received a dose of a Boostrix which was already expired on 8th October 2021. Number for GlaxoSmithKline Medical Information was given as for future reference and warm transfer was provided. NDC number was provided as 5816084252. The reporter consented to follow up.
After both shots Within a few days I experienced higher than normal blood pressure. I consulted my doctor and they changed my medication but this did not help.
approx 50 mins p/inject reported swelling sl to wrist, skin discoloration of arm of inject; denies numbness; t96.2;
In the last 48 hours, have you had a fever* OR symptoms that are unrelated to a preexisting illness?: New cough, New sore throat (SINUS CONGESTION AND DRAINAGE; SNEEZING)
Severe Headache, Fever, Fatigue  Tylenol  24 hours
This case was reported by a consumer and described the occurrence of delays in development in her 14 month old daughter who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix). This case has not been verified by a physician or health care professional.   The subject's medical history, concurrent conditions, and concurrent medications were not reported.  On 04Nov02 at two months of age, the pt received the first dose of Infanrix. The mother of the pt reported that her daughter received her second dose one year later. This represented a schedule of one year between the first and second doses which is longer than the recommended schedule of two months between first and second doses of Infanrix. On an unspecified date in 2003, the pt reportedly developed "developmental delays in speech, eating solid foods, and walking".
I had a cough which got much worse. Fever: 100-101, cough and need to urinate made first night's sleep very unpleasant, waking about every hour, difficulty falling asleep due to severe coughing.
Rec'd immunization in AM, and brought to the ER in the evening due to high fever and fussiness (103.4 rectally per mom).  Infant was 37.7 rectally in ER.  No tylenol was given prior to ER visit.
I AM HAVE NUMBNESS IN MY FACE , TEETH , ARM RIGHT  SIDE GOING DOWN TO  MY TOES ON THE RIGHT SIDE DIZZY WHEN I GET UP FROM A SETTING
Dry like a dermatitis with itch; Dry like a dermatitis with itch; Dry like a dermatitis with itch; my sister has a rash to both hands/and to the outer aspect of one ankle 1 day after getting the Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Dry like a dermatitis with itch), DRY SKIN (Dry like a dermatitis with itch), DERMATITIS (Dry like a dermatitis with itch) and RASH (my sister has a rash to both hands/and to the outer aspect of one ankle 1 day after getting the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Dry like a dermatitis with itch), DRY SKIN (Dry like a dermatitis with itch), DERMATITIS (Dry like a dermatitis with itch) and RASH (my sister has a rash to both hands/and to the outer aspect of one ankle 1 day after getting the Moderna vaccine). At the time of the report, PRURITUS (Dry like a dermatitis with itch), DRY SKIN (Dry like a dermatitis with itch), DERMATITIS (Dry like a dermatitis with itch) and RASH (my sister has a rash to both hands/and to the outer aspect of one ankle 1 day after getting the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported No concomitant medication were reported
Patient received first dose of Pfizer on 6/10/21 - this is 5 days  prior to the second dose that was administered at the public health community vaccination clinic. Patient was informed at the vaccination station of the error. Patient appeared knowledgeable regarding the appropriate time interval. Patient was then further counseled while in the 15 minute wait area, but refused to complete the 15 minute wait time.
08/02/04 noticed poor peripheral vision episode around 10PM, 8/3/04 awakened at 1:00AM with severe headache which lasted most of morning. Has continued to have dull headache which lessens daily c/o nausea, stiff neck and jaw pain.
Information has been received from a mother concerning her 16 year old daughter who in February 2007, was vaccinated with Gardasil. In February 2007, the patient experienced difficulty breathing, unbalanced feeling, "panic attack" and pressure on her chest. On 30-APR-2007 the patient received her second dose of the vaccine and again experienced unbalanced feeling, "panic attack" pressure on her chest and difficulty breathing. This is one of three reports received from the mother. These reactions occurred in less severe from than her older sister which was reported in WAES #0705USA03593. No further details were provided. Additional information has been requested. This is in follow-up to report (s) previously sumbitted on 6/14/2007.
Reporter indicated that Engerix-B was administered & it was determined that 3 pts were non-responders in the last six months;
Pt received PREVNAR 13 vaccination in (R) deltoid on 12/14/15. Pt called PCP on 12/21/2015 reporting a reaction after receiving the vaccination - developed a rash approximately the size of a tennis ball at injection site with a lump under the skin. At that time was reporting that the rash had diminished somewhat, but still persisted. Denied any other symptoms.
He started with tactile fever, severe body ache, chills, intermittent severe headache, dizziness, nauseous and decrease appetite right after he received his immunizations, TRUMENBA, MCV4 and FLULAVAL. The following day his symptoms worsened, he started with lower back pain, dysuria and increased urination, he was urinating every 30 min for 12 hrs. His headache and back pain worsened. Symptoms: fever, headache, severe body aches, dizziness, nauseous, lower back pain, increased urination (every 30 min for 12 hrs), dysuria: x 3 days.
Upper left arm swelling; upper arm Erythema; skin warm; This case was reported by a physician via sales rep and described the occurrence of swelling arm in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received Shingrix (intramuscular). On an unknown date, 3 days after receiving Shingrix, the patient experienced swelling arm, erythema of extremities and skin warm. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the swelling arm, erythema of extremities and skin warm were recovered/resolved.   It was unknown if the reporter considered the swelling arm, erythema of extremities and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided, but it could be 59 to 60 years. The patient experienced upper left arm swelling, with redness and warmth that improved after steroid administration.   No further details available. The reporter was unable to provide business address or phone number for reporter.   The reporter prefers email contact.
Swollen right earlobe; Itching; Hives on right arm, neck chest and waist; This spontaneous case was reported by a consumer and describes the occurrence of EAR SWELLING (Swollen right earlobe), PRURITUS (Itching) and URTICARIA (Hives on right arm, neck chest and waist) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 29-Jan-2021, the patient experienced URTICARIA (Hives on right arm, neck chest and waist).   On an unknown date, the patient experienced EAR SWELLING (Swollen right earlobe) and PRURITUS (Itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency.   At the time of the report, EAR SWELLING (Swollen right earlobe), PRURITUS (Itching) and URTICARIA (Hives on right arm, neck chest and waist) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.